news
Many people may not receive a COVID-19 vaccine until 2022
Studies show that more than a fifth of the global population, mostly in low- and middle-income countries, may have to wait until at least 2022 to receive a COVID-19 vaccine.
List view / Grid view
Johns Hopkins Bloomberg School of Public Health
news
Report shows US brand-name drug prices ‘highest in the world’
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
news
Inadequate FDA oversight concerning fentanyl prescriptions
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
news
Rotavirus vaccine cuts infant diarrhoea deaths in Malawi
"The key message of this paper is that to do the best by all our children and to help them survive, all countries should introduce rotavirus vaccination.”
news
Blood-based epigenetic may hold clues to autism
Epigenetic data reveals immune-response pathways that may prove critical to understanding autism...
news
A path toward ending AIDS epidemic in the US by 2025
15 May 2017 | By Niamh Marriott, Junior Editor
A new study describes an ambitious but feasible path toward what may have seemed unachievable just a decade ago: an end to the AIDS epidemic in the US...
news
The global cost of norovirus
26 April 2016 | By Victoria White, Digital Content Producer
Norovirus results in roughly $4.2 billion in health care costs and $60.3 billion in societal costs annually, a new study has found...
